Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Queensland Health
Johnson and Johnson
Cerilliant
AstraZeneca
Daiichi Sankyo
McKesson
Covington
Express Scripts

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,861,411

« Back to Dashboard

Which drugs does patent 6,861,411 protect, and when does it expire?

Patent 6,861,411 protects AZASITE and is included in one NDA.

This patent has nine patent family members in ten countries.
Summary for Patent: 6,861,411
Title: Method of treating eye infections with azithromycin
Abstract:The invention features methods and compositions for treating ocular infections. The method comprises topically administering to an eye of an animal in need of such treatment an ocular infection-treating amount of azithromycin.
Inventor(s): Ahmed; Imran (East Lyme, CT)
Assignee: Pfizer, Inc. (New York, NY)
Application Number:09/200,119
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 6,861,411

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Oak Pharms Inc AZASITE azithromycin SOLUTION/DROPS;OPHTHALMIC 050810-001 Apr 27, 2007 RX Yes Yes ➤ Subscribe ➤ Subscribe METHOD OF COMBATING BACTERIA IN A PATIENT ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,861,411

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 271390 ➤ Subscribe
Brazil 9805318 ➤ Subscribe
Canada 2254682 ➤ Subscribe
Germany 69825128 ➤ Subscribe
Denmark 0925789 ➤ Subscribe
European Patent Office 0925789 ➤ Subscribe
Spain 2221127 ➤ Subscribe
Japan H11240838 ➤ Subscribe
Mexico 232591 ➤ Subscribe
Portugal 925789 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Colorcon
Fuji
Citi
Medtronic
QuintilesIMS
Mallinckrodt
US Army
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot